warnings
WARNINGS Keep out of reach of children.
FDA label 0bba9dd1-a3ea-4df2-95fe-e9b2c698343c
openFDA label record#
This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.
Verified complete openFDA source JSON
- SPL set ID
- 922614aa-8c26-4e34-94f1-da9119eb6219
- SPL ID
- 0bba9dd1-a3ea-4df2-95fe-e9b2c698343c
- Version
- 3
- Effective date
- 2024-12-19
- Source export date
- 2026-09-28
- Source partition
- 6
- Source file
- https://download.open.fda.gov/drug/label/drug-label-0006-of-0014.json.zip
- Source object key
- raw/openfda/drug-label/2026-09-28/e0861bcde1444ef952820955caafc6f3fd29783e5ade07a13d933aa3336b399f/drug-label-0006-of-0014.json.zip
- Source manifest SHA-256
- cd2e66336a5cd2223fa3995098fdbdb84c6a7ee5c0a4addb236ccb22dd1e6887
- Import run
- 20260929T050834Z
- Imported at
- 2026-09-29 05:39:06
Harmonized identifier links#
Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.
| Type | Scope | Identifier | Source field |
|---|---|---|---|
| spl id | 0bba9dd1-a3ea-4df2-95fe-e9b2c698343c | id | |
| spl set id | 922614aa-8c26-4e34-94f1-da9119eb6219 | set_id |
Warnings cross-check#
openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.
Adverse reactions cross-check#
openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.
adverse reactions
ADVERSE REACTIONS The following local adverse reactions are reported infrequently with topical corticosteroids, but may occur more frequently with the use of occlusive dressings. These reactions are listed in an approximate decreasing order of occurrence: Burning Hypertrichosis Maceration of the skin Itching Acneiform eruptions Secondary infection Irritation Hypopigmentation Skin atrophy Dryness Perioral dermatitis Striae Folliculitus Allergic contact dermatitis Miliaria In controlled clinical studies the incidence of adverse reactions was low (0.3%) for desoximetasone ointment, 0.25% and consisted of development of comedones at the site of application.
adverse reactions table
<table><col/><col/><col/><tbody><tr><td align="center" valign="top"> Burning</td><td align="center" valign="top"> Hypertrichosis</td><td align="center" valign="top"> Maceration of the skin</td></tr><tr><td align="center" valign="top"> Itching</td><td align="center" valign="top"> Acneiform eruptions</td><td align="center" valign="top"> Secondary infection</td></tr><tr><td align="center" valign="top"> Irritation</td><td align="center" valign="top"> Hypopigmentation</td><td align="center" valign="top"> Skin atrophy</td></tr><tr><td align="center" valign="top"> Dryness</td><td align="center" valign="top"> Perioral dermatitis</td><td align="center" valign="top"> Striae</td></tr><tr><td align="center" valign="top"> Folliculitus</td><td align="center" valign="top"> Allergic contact dermatitis</td><td align="center" valign="top"> Miliaria</td></tr></tbody></table>
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.